.
MergerLinks Header Logo

Announced

Haemonetics to acquire Cardiva Medical for $510m.

Financials

Edit Data
Transaction Value£374m
Consideration TypeContingent Deferred Consideration, Cash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Medical Equipment

Pending

vascular closure systems

Acquisition

Private

Domestic

United States

Single Bidder

Friendly

Majority

Private Equity

Synopsis

Edit

Haemonetics, a global provider of blood and plasma supplies and services, agreed to acquire Cardiva Medical, a manufacturer of vascular closure systems, for $510m, comprising of a $475m upfront payment in cash and $35m in contingent consideration based on sales growth. The acquisition is subject to customary closing conditions and is expected to be completed in the first quarter of calendar 2021. "We are excited to add Cardiva's vascular closure technology to our portfolio and look forward to welcoming their talented team. This acquisition immediately expands and diversifies our hospital offerings in the large and growing interventional cardiology and electrophysiology markets and aligns with our innovation agenda," Chris Simon, Haemonetics President and CEO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US